English

UCHealth Recruits Volunteers to Test Vaccine

UCHealth recluta voluntarios UCHealth Recruits Volunteers

TEST BY UCHEALTH

Newsroom El Comercio de Colorado

Haga click aquí para leer la versión en español

UCHealth has begun recruiting healthy adults to test the Modern Laboratory’s COVID-19 vaccine. This phase 3 study is being conducted to evaluate the safety and effectiveness of mRNA-1273, a candidate vaccine for use on racial and ethnic minorities at increased risk for COVID-19. Essential workers in close contact with potentially infected people would also be tested.

The phase 3 study will evaluate whether the mRNA-1273 vaccine stimulates the immune system to produce enough antibodies against SARS-CoV-2, the virus that causes COVID-19. The goal is to attack it so that it does not cause the disease in cases of infection. “We encourage people in the Denver area to consider participating in this trial, which could bring the world closer to the end of this global health crisis,” said Thomas Campbell, MD, Principal Investigator at UCHealth.

Who is Elegible?

To be eligible for the study, healthy volunteers must be 18 years or older, with no known history of SARS-CoV-2 infection and must not have previously participated in a study of an investigational vaccine for coronavirus. In this group, UCHealth prioritizes candidates whose locations or circumstances put them at higher risk of exposure to the virus, including seniors 65 years and older.

They also look for essential workers in close contact with potentially infected people including but not limited to hospital and healthcare workers, lifeguards, transit employees, residents or workers in institutions, factory employees, and teachers and students. Critical to this trial are racial and ethnic minorities at high risk for COVID-19.

Interesados deben llamar

(303)724-0775

Volunteers for 25 Months

If an individual is eligible and chooses to participate, the research staff at UCHealth will randomly select patients to receive the mRNA-1273 vaccine or a placebo equivalent. The total duration of participation is 25 months and includes approximately seven clinic visits and 24 phone calls. UCHealth is one of 89 research centers across the country participating in the COVE study.